A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
This study will determine the appropriate dose and frequency of administration of iv Mircera
maintenance therapy in hemodialysis patients with chronic renal anemia who were previously
receiving iv epoetin. The anticipated time on study treatment is 3-12 months and the target
sample size is <100 individuals.